Russell C Hirsch
CIK 1162059 · last filed 2014-10-01
Russell C Hirsch is a corporate insider who has filed 18 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for VTAE, was dated Oct 1, 2014. Across all open-market trades the lifetime net is +$6.4M, making them a net buyer over the disclosed history. 16 SEC filings were submitted jointly with PROSPECT MANAGEMENT CO II LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VTAE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 200
PALO ALTO, CA 94301
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | 10%+ Owner | 1,900,716 | — | — | $5.37M | 1 | 2014-10-01 |
| BAXANO SURGICAL, INC. (BAXS) Delisted | Director | 2,009,806 | — | — | $4.58M | 1 | 2013-06-04 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 1,788,647 | — | — | $0 | 1 | 2013-05-30 |
| HANSEN MEDICAL INC (HNSN) Delisted | Director | 6,633 | — | — | $1.25M | 12 | 2012-05-30 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | 127,014 | $15.00 | $1.91M | -$4.81M | 3 | 2010-12-03 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-10-01 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Mixed | +2,905,280 | $5.37M | EDGAR |
| 2013-06-04 | BAXANO SURGICAL, INC. (BAXS) Delisted | Mixed | +5,340,616 | $4.58M | EDGAR |
| 2013-05-30 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Conv (C) | +1,815,884 | $0 | EDGAR |
| 2012-05-30 | HANSEN MEDICAL INC (HNSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-06-17 | HANSEN MEDICAL INC (HNSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-12-03 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −322,408 | -$4.81M | EDGAR |
| 2010-07-08 | HANSEN MEDICAL INC (HNSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-06-25 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-04-23 | HANSEN MEDICAL INC (HNSN) Delisted | Buy (P) | +125,000 | $250.0K | EDGAR |
| 2010-03-18 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Conv (C) | +1,611,891 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.